SFMG Wealth Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,338
Closed -$1.65M 155
2018
Q4
$1.65M Buy
12,338
+245
+2% +$40.2K 0.27% 34
2018
Q3
$1.97M Sell
12,093
-65
-0.5% -$11.9K 0.3% 28
2018
Q2
$2.03M Buy
12,158
+2,880
+31% +$462K 0.33% 28
2018
Q1
$1.56M Buy
9,278
+3,258
+54% +$546K 0.26% 30
2017
Q4
$985K Buy
+6,020
New +$1.08M 0.16% 45
2016
Q4
Sell
-7,636
Closed -$1.76M 123
2016
Q3
$1.76M Buy
+7,636
New +$1.87M 0.39% 34
2016
Q1
Sell
-2,180
Closed -$681K 121
2015
Q4
$681K Buy
+2,180
New +$649K 0.16% 61

Other funds holding AGN

SFMG Wealth Advisors's AGN Position: Q1 2019 in Review

SFMG Wealth Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 12,338 shares — an estimated $1.65M sold.

SFMG Wealth Advisors first reported a position in AGN in Q4 2015 and held it in 7 quarters. The position peaked at $2.03M in Q2 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • SFMG Wealth Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • SFMG Wealth Advisors sold 12,338 Allergan plc shares in Q1 2019, an estimated $1.65M.
  • SFMG Wealth Advisors first reported a position in Allergan plc in Q4 2015 and held it in 7 quarters.
  • SFMG Wealth Advisors's Allergan plc position peaked at $2.03M in Q2 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on SFMG Wealth Advisors's 13F filing for Q1 2019, filed 13 May 2019.